4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-23-035409
Chief Medical Officer sold 5,000 shares at $25.95 ($129,727)
- Chief Medical Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2023-06-07 | Option exercise 10b5-1 | +5,000 | $1.53 | $7,650 | 193,000 | D |
| Pang Phillip Chief Medical Officer | 2023-06-07 | Sale 10b5-1 | −5,000 | $25.95 | $129,727 | 188,000 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2023-06-07 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 47,591 | D | ||
| Open-market sales · 5,000 sh · avg $25.95 · $129,727 | |||||||
Loading xslF345X04/doc4.xml…